Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 92101-92150 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05380570
Epidemiological Study of Korean Radiation Workers
N/A
Active, not recruiting
196,379 participants
Started: Nov 18, 2021 · Completed: Mar 31, 2031
4 conditions
1 sponsor
1 location
NCT04971044
Competency Based Approaches for Community Health 2
NA
Active, not recruiting
301 participants
Started: Nov 18, 2021 · Completed: Oct 31, 2026
1 condition
5 sponsors
1 location
NCT05968352
Restoration of Bladder Function in Spinal Cord Injury
N/A
Recruiting
10 participants
Started: Nov 18, 2021 · Completed: May 31, 2026
2 conditions
1 sponsor
1 location
NCT05230446
PRospective Evaluation of Complete Revascularization in Patients With multiveSsel Disease Excluding chroNic Total Occlusions
NA
Recruiting
609 participants
Started: Nov 18, 2021 · Completed: Nov 18, 2027
7 conditions
1 sponsor
1 location
NCT05042921
Pediatric Spinal Muscular Atrophy (SMA) China Registry
N/A
Active, not recruiting
600 participants
Started: Nov 18, 2021 · Completed: Sep 2, 2027
1 condition
1 sponsor
25 locations
NCT04898790
Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
NA
Recruiting
88 participants
Started: Nov 18, 2021 · Completed: Jul 31, 2027
5 conditions
1 sponsor
1 location
NCT05729542
Comparing Clinical Outcomes of Suture Button Versus Fibulink Fixation for Acute Ankle Syndesmosis Injuries
NA
Recruiting
140 participants
Started: Nov 18, 2021 · Completed: Nov 18, 2027
3 conditions
1 sponsor
1 location
NCT04662294
CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases
EARLY_PHASE1
Recruiting
108 participants
Started: Nov 18, 2021 · Completed: Jan 15, 2027
3 conditions
2 sponsors
1 location
NCT04925193
Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma
PHASE2
Active, not recruiting
18 participants
Started: Nov 18, 2021 · Completed: Nov 30, 2026
1 condition
3 sponsors
1 location
NCT05091567
A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer
PHASE3
Active, not recruiting
660 participants
Started: Nov 18, 2021 · Completed: Aug 13, 2026
1 condition
2 sponsors
92 locations
NCT04842266
IlluminOss Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pelvis Fractures
N/A
Recruiting
100 participants
Started: Nov 18, 2021 · Completed: Dec 31, 2027
3 conditions
3 sponsors
1 location
NCT04983823
Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)
NA
Recruiting
820 participants
Started: Nov 18, 2021 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05139797
Artificial Intelligence Guided Echocardiographic Screening of Rare Diseases (EchoNet-Screening)
N/A
Recruiting
300 participants
Started: Nov 18, 2021 · Completed: Jun 1, 2027
1 condition
1 sponsor
1 location
NCT05006833
Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness
NA
Active, not recruiting
21,110 participants
Started: Nov 18, 2021 · Completed: Mar 30, 2026
1 condition
2 sponsors
1 location
NCT05007925
Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System
NA
Active, not recruiting
250 participants
Started: Nov 18, 2021 · Completed: Apr 1, 2026
1 condition
1 sponsor
43 locations
NCT05559645
Assessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EGFR Mutations (WU-KONG15)
NA
Recruiting
180 participants
Started: Nov 18, 2021 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT03990896
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial
PHASE2
Recruiting
30 participants
Started: Nov 18, 2021 · Completed: Mar 31, 2027
1 condition
2 sponsors
7 locations
NCT05087056
Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents
PHASE2
Active, not recruiting
302 participants
Started: Nov 18, 2021 · Completed: Feb 5, 2027
1 condition
1 sponsor
30 locations
NCT05163080
SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)
PHASE2
Active, not recruiting
247 participants
Started: Nov 18, 2021 · Completed: Aug 18, 2024
1 condition
3 sponsors
11 locations
NCT05141643
Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer
EARLY_PHASE1
Active, not recruiting
30 participants
Started: Nov 18, 2021 · Completed: Nov 18, 2026
2 conditions
1 sponsor
1 location
NCT04856488
Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter
PHASE3
Recruiting
182 participants
Started: Nov 18, 2021 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT05121779
Head-to-head Comparison of Diagnosis Value of Pulmonary Fibrosis on 68Ga-FAPI-04 and 18F-FDG PET-CT
PHASE1
Recruiting
80 participants
Started: Nov 18, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04549311
Perianal Abscess Recurrence and Fistula Formation: Antibiotics Following Incision and Drainage Trial
PHASE3
Active, not recruiting
15 participants
Started: Nov 18, 2021 · Completed: Apr 1, 2024
2 conditions
1 sponsor
3 locations
NCT05134441
Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
PHASE3
Recruiting
1,050 participants
Started: Nov 18, 2021 · Completed: Sep 30, 2032
1 condition
1 sponsor
86 locations
NCT05012254
Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases
PHASE2
Active, not recruiting
71 participants
Started: Nov 18, 2021 · Completed: Dec 15, 2026
3 conditions
1 sponsor
18 locations
NCT05064813
MBSR Mechanisms in GAD
NA
Recruiting
150 participants
Started: Nov 18, 2021 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT04136535
Pemetrexed and Carboplatin With or Without Anlotinib Hydrochloride for Osimertinib-resistant Non-squamous NSCLC
PHASE2
Recruiting
105 participants
Started: Nov 18, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05143996
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
PHASE1
Recruiting
60 participants
Started: Nov 18, 2021 · Completed: Nov 30, 2025
2 conditions
1 sponsor
7 locations
NCT05160584
A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma
N/A
Recruiting
300 participants
Started: Nov 18, 2021 · Completed: May 31, 2028
1 condition
1 sponsor
80 locations
NCT03953703
Levocarnitine for Dry Eye in Sjogren's Syndrome
PHASE2
Active, not recruiting
15 participants
Started: Nov 17, 2021 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05024864
HELicobacter Pylori Screening to Prevent Gastrointestinal Bleeding in Patients With Acute Myocardial Infarction
NA
Active, not recruiting
20,000 participants
Started: Nov 17, 2021 · Completed: Jan 17, 2030
4 conditions
4 sponsors
35 locations
NCT05553314
Carvedilol in HF With Preserved EF
PHASE4
Recruiting
100 participants
Started: Nov 17, 2021 · Completed: Dec 30, 2024
3 conditions
3 sponsors
2 locations
NCT04948671
Primary Hyperparathyroidism and Gut Microbiota
N/A
Recruiting
90 participants
Started: Nov 17, 2021 · Completed: Feb 28, 2026
1 condition
2 sponsors
1 location
NCT05238792
Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients with High Risk Solid Tumors
PHASE1
Recruiting
36 participants
Started: Nov 17, 2021 · Completed: Oct 31, 2027
1 condition
1 sponsor
1 location
NCT05089734
Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
PHASE3
Active, not recruiting
603 participants
Started: Nov 17, 2021 · Completed: Jan 31, 2026
1 condition
1 sponsor
227 locations
NCT05145127
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
PHASE3
Recruiting
245 participants
Started: Nov 17, 2021 · Completed: Jul 31, 2030
2 conditions
1 sponsor
60 locations
NCT06124222
Prosthetic Rehabilitation and Its Influence on Masticatory Performance and QoL in Patients Treated for HNC
NA
Enrolling by invitation
21 participants
Started: Nov 17, 2021 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT04812925
A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients with Primary Immune Thrombocytopenia
PHASE3
Active, not recruiting
173 participants
Started: Nov 17, 2021 · Completed: Oct 1, 2026
1 condition
1 sponsor
83 locations
NCT05756582
Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students
N/A
Recruiting
2,040 participants
Started: Nov 17, 2021 · Completed: Dec 15, 2026
5 conditions
1 sponsor
1 location
NCT04413097
Delayed Cord Clamping With Oxygen In Extremely Low Gestation Infants
NA
Active, not recruiting
140 participants
Started: Nov 17, 2021 · Completed: May 31, 2026
5 conditions
3 sponsors
3 locations
NCT05128695
Public Health Consequences of Covid-19
N/A
Enrolling by invitation
60,000 participants
Started: Nov 17, 2021 · Completed: Dec 1, 2025
1 condition
5 sponsors
1 location
NCT05328882
Early Recurrences of Atrial Arrhythmias and Their Impact on Late Recurrence After Pulmonary Vein Isolation With Pulsed Field Ablation of Paroxysmal Atrial Fibrillation
N/A
Recruiting
40 participants
Started: Nov 17, 2021 · Completed: May 17, 2024
2 conditions
1 sponsor
1 location
NCT04927351
Nudges for Opioid Reduction After Major Surgery Trial
NA
Active, not recruiting
484 participants
Started: Nov 17, 2021 · Completed: Dec 1, 2024
1 condition
2 sponsors
1 location
NCT04968288
Natural History of KSHV-Associated Multicentric Castleman s Disease
N/A
Recruiting
195 participants
Started: Nov 17, 2021 · Completed: Jan 1, 2035
1 condition
1 sponsor
1 location
NCT06815406
Recurrence Rate After Endoscopic Resection of , Laterally Spreading Tumor Granular Type (LST-G) of the Colon and Rectum: Endoscopic Mucosal Resection Vs. Endoscopic Submucosal Dissection
NA
Recruiting
282 participants
Started: Nov 17, 2021 · Completed: May 31, 2026
1 condition
1 sponsor
5 locations
NCT05026138
Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
N/A
Recruiting
850 participants
Started: Nov 17, 2021 · Completed: Mar 31, 2047
1 condition
1 sponsor
1 location
NCT06746896
Retrospective Study on the Role of SCFA Modulation in Multiple Sclerosis
N/A
Active, not recruiting
40 participants
Started: Nov 17, 2021 · Completed: Sep 30, 2025
1 condition
2 sponsors
1 location
NCT07169396
Identifying Genetic Targets in Gynecological Tumors
N/A
Recruiting
180 participants
Started: Nov 17, 2021 · Completed: Nov 30, 2027
1 condition
1 sponsor
1 location
NCT05081557
A Study to Assess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic Dermatitis
N/A
Active, not recruiting
873 participants
Started: Nov 17, 2021 · Completed: Oct 31, 2026
1 condition
1 sponsor
140 locations
NCT04958265
A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
PHASE3
Active, not recruiting
41 participants
Started: Nov 17, 2021 · Completed: May 19, 2029
1 condition
2 sponsors
22 locations
Previous
1
More pages
1840
1841
1842
1843
1844
1845
1846
More pages
2369
Next